Cellebrite DI announced its half-year 2025 results, reporting revenue of US$220.83 million, a turnaround to net income of US$36.88 million, and the appointment of Thomas E. Hogan as CEO, following his ...

Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Small Cap Growth Fund” second-quarter ...

Greenhaven Road Capital, an investment management company, released its second-quarter 2025 investor letter. A copy of the ...

Cellebrite (CLBT) boasts strong growth potential with robust financials, digital forensics leadership, and a durable moat.

Investors in Cellebrite DI Ltd (Symbol: CLBT) saw new options become available this week, for the May 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ...

For comparison, CLBT has a P/B of 12.85. These are just a few of the metrics contributing to NU's Value grade of B and CLBT's Value grade of D.

Understand the cash flow statement for Cellebrite DI Ltd. (CLBT), learn where the money comes from and how the company spends it.

Cellebrite DI Ltd. (CLBT) key stats comparison: compare with other stocks by metrics: valuation, growth, profitability, momentum, EPS revisions, dividends, ratings.